ESR1 and breast cancer: Importantly, the SP decreased cell viability of not only ER-positive cell lines, but also ER-negative BC cell lines MDA-MB-231 and MDA-MB-157, while the immortalized noncancerous MCF10A human mammary epithelial control cells were not significantly affected by SP treatment.